跳至主要内容
临床试验/NCT04473742
NCT04473742已完成不适用

Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages

Rennes University Hospital2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2021年3月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
23
试验地点
2
主要终点
Efferocytosis Index (EI) calculation (%) defined as the number of efferocyte MDM / total number of MDM

研究概览

简要总结

Evaluation of the efferocytosis capacities of blood Monocyte Derived Macrophages (MDM) from patients with a history of asbestosis or silica exposure and comparison of these capacities with those of MDM from healthy donors.

详细描述

Patients with a proven history or current exposure will have 4 EDTA tubes drawn, approximately 24mL of fresh whole blood for efferocytosis assessment and :

  • 2 x 6mL serum tubes for the assessment of Antinuclear Antibody (ANA) positivity, serum high-mobility group box 1 (HMGB1) and osteopontin for patients exposed to asbestos
  • 1 x 6mL serum tube for serum HMGB1 and osteopontin for patients exposed to silica

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient older than 18 Yo
  • Addressed to the department of occupational disease
  • With a history of asbestosis or silica exposure evaluated by a dedicated questionnaire and a throughout examination of the history of occupations, according to standard procedures for the follow-up of at risk workers.
  • Persons who received an oral and written information on the protocol and signed the informed consent form

排除标准

  • Pregnant or breastfeeding women
  • Subject legally protected (under judicial protection, guardianship), persons deprived of liberty

结局指标

主要结局

Efferocytosis Index (EI) calculation (%) defined as the number of efferocyte MDM / total number of MDM

时间窗: Through study completion, an average of 2 years

次要结局

  • EI calculation in patients positive for ANA vs patients negative for ANA(Through study completion, an average of 2 years)
  • Serum concentration of HMGB1 and Osteopontin (SPP1) by ELISA(Through study completion, an average of 2 years)

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验